AI is about to change healthcare. These 7 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own New Pacific Metals today, you have to believe that Carangas can transition from a promising study on paper into a permitted, financeable mine. The newly signed 30‑year Administrative Mining Contracts are a meaningful step in that direction, because they move tenure risk at Carangas closer to a political process rather than a purely administrative one, and clear the way for the 30,000 metre drill program that underpins the recent PEA and future feasibility work. In the near term, the key catalysts now sit around legislative ratification in Bolivia and drill results that could refine both scale and mine design, while the stock’s sharp move over the past year suggests some of that optimism is already reflected in the price. The flip side is that New Pacific still has no revenue, ongoing losses, and remains dependent on capital markets to fund this next stage.
However, investors also need to be comfortable with concentrated country and permitting risk. Insights from our recent valuation report point to the potential overvaluation of New Pacific Metals shares in the market.Explore another fair value estimate on New Pacific Metals - why the stock might be worth as much as CA$8.83!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com